Additional file 2: of Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
收藏Figshare2019-04-28 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/Additional_file_2_of_Rapid_decline_of_noninvasive_fibrosis_index_values_in_patients_with_hepatitis_C_receiving_treatment_with_direct-acting_antiviral_agents/8050598/1
下载链接
链接失效反馈官方服务：
资源简介：
Figure S1. APRI and FIB-4 values at different time points in patients without SVR12 (n = 7). APRI (a). FIB-4 (b). APRI, AST/platelet ratio index; SVR12, sustained virologic response at 12 weeks after therapy; BA, baseline; 2W, week 2; 4W, week 4; EOT, end of therapy; PW12, 12 weeks after direct-acting antiviral therapy. All comparisons are made with baseline levels. *P < 0.05. (ZIP 83 kb)
补充图S1。未获得SVR12的患者在不同时间点的APRI与FIB-4水平（n=7）。其中(a)为APRI，(b)为FIB-4。APRI（天冬氨酸氨基转移酶与血小板比率指数，AST/platelet ratio index）；SVR12（治疗后12周持续病毒学应答，sustained virologic response at 12 weeks after therapy）；BA（基线，baseline）；2W（治疗第2周，week 2）；4W（治疗第4周，week 4）；EOT（治疗结束，end of therapy）；PW12（直接抗病毒药物治疗后12周，12 weeks after direct-acting antiviral therapy）。所有比较均以基线水平为参照。*P < 0.05。（ZIP 压缩文件，83 KB）
提供机构：
Chia-Hsin Lin; Po-Heng Chuang; Wei-Fan Hsu; Wen-Pang Su; Hung-Yao Chen; Hung-Wei Wang; Sheng-Hung Chen; Hsueh-Chou Lai; Guan-Tarn Huang
创建时间：
2019-04-28
